BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6321535)

  • 1. Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.
    Jackson RV; DeCherney GS; DeBold CR; Sheldon WR; Alexander AN; Rivier J; Vale W; Orth DN
    J Clin Endocrinol Metab; 1984 Apr; 58(4):740-3. PubMed ID: 6321535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
    DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies with synthetic ovine corticotropin-releasing factor.
    Orth DN; DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Uderman H; Alexander AN; Island DP; Rivier J
    Fed Proc; 1985 Jan; 44(1 Pt 2):197-202. PubMed ID: 2981741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.
    DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Alexander AN; Island DP; Rivier J; Vale W; Orth DN
    J Clin Endocrinol Metab; 1983 Aug; 57(2):294-8. PubMed ID: 6306038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ovine corticotropin-releasing hormone and FK 33-824 (met-enkephalin analogue) on the secretions of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in patients with Addison's disease.
    Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
    Endocrinol Jpn; 1986 Dec; 33(6):761-8. PubMed ID: 3034555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.
    Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
    Endocrinol Jpn; 1986 Oct; 33(5):713-9. PubMed ID: 3030713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low dose ovine corticotropin-releasing hormone in humans: endocrine relationships and beta-endorphin/beta-lipotropin responses.
    Watson SJ; Lopez JF; Young EA; Vale W; Rivier J; Akil H
    J Clin Endocrinol Metab; 1988 Jan; 66(1):10-5. PubMed ID: 2826522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides.
    Margioris AN; Grino M; Protos P; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1988 May; 66(5):922-6. PubMed ID: 2834412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T; Takahashi H; Ibayashi H; Nobunaga M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
    Castro M; Moreira AC
    Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Kamilaris TC; Island DP; Orth DN
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1211-8. PubMed ID: 3033009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone: stimulation of ACTH secretion in normal man.
    DeBold C; Orth DN; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Island DP
    Horm Metab Res Suppl; 1987; 16():8-16. PubMed ID: 2832299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of plasma immunoreactive adrenocorticotropin, beta-endorphin/beta-lipotropin, gamma-lipotropin and cortisol to experimentally induced pain in normal subjects.
    Güllner HG; Nicholson WE; Wilson MG; Bartter FC; Orth DN
    Clin Sci (Lond); 1982 Oct; 63(4):397-400. PubMed ID: 6286207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency.
    Peterson ME; Kemppainen RJ; Orth DN
    Am J Vet Res; 1992 Mar; 53(3):421-5. PubMed ID: 1317690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.